SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000850261-18-000013
Filing Date
2018-03-16
Accepted
2018-03-16 17:19:14
Documents
132
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K srne12312017-10k.htm 10-K 2238497
2 EXHIBIT 12.1 exhibit121.htm EX-12.1 29702
3 EXHIBIT 21.1 exhibit211.htm EX-21.1 19285
4 EXHIBIT 23.1 ex231.htm EX-23.1 3186
5 EXHIBIT 23.2 exhibit232.htm EX-23.2 2708
6 EXHIBIT 31.1 exhibit311.htm EX-31.1 12181
7 EXHIBIT 31.2 exhibit312.htm EX-31.2 12056
8 EXHIBIT 32.1 exhibit321.htm EX-32.1 7468
15 a2017performancegraph.jpg GRAPHIC 80418
16 painfranchise.jpg GRAPHIC 94951
17 sorrentoimage2a01.jpg GRAPHIC 26870
18 srnepartnersa01.jpg GRAPHIC 182628
19 technologygrapha01.jpg GRAPHIC 267012
  Complete submission text file 0000850261-18-000013.txt   13733033

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT srne-20171231.xml EX-101.INS 2267043
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20171231.xsd EX-101.SCH 109453
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20171231_cal.xml EX-101.CAL 148308
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20171231_def.xml EX-101.DEF 751950
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20171231_lab.xml EX-101.LAB 1273010
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20171231_pre.xml EX-101.PRE 964083
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36150 | Film No.: 18696652
SIC: 8731 Services-Commercial Physical & Biological Research